Successful treatment with metronidazole and paromomycin for fulminant amoebic colitis during cytotoxic chemotherapy in a patient with small-cell lung cancer

Bibliographic Details
Title: Successful treatment with metronidazole and paromomycin for fulminant amoebic colitis during cytotoxic chemotherapy in a patient with small-cell lung cancer
Authors: Aya Kitaoka, Kazuya Tanimura, Yuto Yasuda, Kensuke Nishioka, Yutaka Hirayama, Kiyoshi Uemasu, Daisuke Iwashima, Sou Arita, Toshiyuki Kitai, Susumu Hoshi, Emi Date, Norishige Iizuka, Ken-ichi Takahashi
Source: IDCases, Vol 26, Iss , Pp e01337- (2021)
Publisher Information: Elsevier, 2021.
Publication Year: 2021
Collection: LCC:Infectious and parasitic diseases
Subject Terms: Entamoeba histolytica, Fulminant amebic colitis, Activation, Chemotherapy, Small-cell lung cancer, Infectious and parasitic diseases, RC109-216
More Details: We report the case of a 64-year-old man with advanced small-cell lung cancer who developed fulminant amoebic colitis during cytotoxic chemotherapy. During the first cycle of carboplatin/etoposide treatment, febrile neutropenia and grade 4 neutropenia developed. Because diarrhea, abdominal pain, and bloody stool were observed, abdominal computed tomography was performed, showing intussusception, and extensive colectomy and colostomy were performed. Histopathology of the colon revealed gastrointestinal necrosis and perforation due to Entamoeba histolytica infection. Amoebiasis improved after treatment with metronidazole and paromomycin. The second cycle of carboplatin/etoposide with dose reduction was completed, resulting in a partial response to small-cell lung cancer.The results of this case suggest that paromomycin is an additional option for amoebiasis during cytotoxic chemotherapy, and persistent diarrhea during cytotoxic chemotherapy should alert clinicians to consider the development of amoebiasis.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2214-2509
Relation: http://www.sciencedirect.com/science/article/pii/S2214250921002936; https://doaj.org/toc/2214-2509
DOI: 10.1016/j.idcr.2021.e01337
Access URL: https://doaj.org/article/dc440a34809c48368a23a348d348c76f
Accession Number: edsdoj.440a34809c48368a23a348d348c76f
Database: Directory of Open Access Journals
More Details
ISSN:22142509
DOI:10.1016/j.idcr.2021.e01337
Published in:IDCases
Language:English